BIOMARKER

QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery

51 views May 14, 2024

Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications...

QIAGEN OmicSoft and Biomedical Knowledge Base

Integrating deeply curated omics data with APIs for biomarkers and drug...

114 views April 15, 2024

This webinar is for data scientists and bioinformaticians who need extensive...

Gene Variant Databases

Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls,...

144 views March 13, 2024

The cancer drug discovery landscape is shifting. While research continues to grow in...

QIAGEN OmicSoft and Biomedical Knowledge Base

Biomarker discovery, target validation, and variant identification using...

132 views February 29, 2024

In this webinar, users will learn how to leverage solutions from QIAGEN Digital...

QIAGEN OmicSoft and Biomedical Knowledge Base

Target exploration and cell line selection for drug discovery

173 views December 18, 2023

Cancer cell line models have been a cornerstone of cancer research for decades....

QIAGEN OmicSoft and Biomedical Knowledge Base

Mining curated knowledge graphs and validating with experimental datasets to...

286 views December 11, 2023

In an era of near-limitless public experimental data but little standardization,...

QIAGEN OmicSoft and Biomedical Knowledge Base

Exploring pan-cancer immunomodulators for biomarker discovery and validation...

149 views October 12, 2023

Cancer outcome is influenced by both the tumor microenvironment and host immune...

QIAGEN IPA

Cross-species comparison and validation for drug discovery and biomarker...

172 views September 27, 2023

Some human studies may be unfeasible or unethical, making cross-species research...

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment, toxicology and target safety assessment using QIAGEN IPA and...

155 views September 06, 2023

In this 90-minute training, you'll learn how to perform drug treatment, toxicology and...

QIAGEN IPA

Interpreting genetic risk loci from GWAS in the context of key genes and...

245 views August 16, 2023

Genome-wide association studies (GWAS) provide insights into the genetic architecture...

QIAGEN OmicSoft and Biomedical Knowledge Base

Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity...

295 views August 16, 2023

Research and development for new drugs and disease treatments can be lengthy and...